Strategies for Maintenance Therapies in Advanced Non Small Cell Lung Cancer
Phase III Study Evaluating Two Strategies of Maintenance, One With Pemetrexed in Continuous Strategy and One According to the Response of Induction Chemotherapy, in Non Squamous Non Small Cell Lung Cancer of Advanced Stage
Sponsor: Groupe Francais De Pneumo-Cancerologie
This PHASE3 trial investigates Advanced Non Small Cell Lung Cancer and is currently completed. Groupe Francais De Pneumo-Cancerologie leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Feb 2018 — Jun 2018 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Jan 2017 — Feb 2018 [monthly]
Active Not Recruiting PHASE3
First recorded
Jul 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Groupe Francais De Pneumo-Cancerologie
- Intergroupe Francophone de Cancerologie Thoracique
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Abbeville, France , Aix-en-Provence, France , Albi, France , Ambilly, France , Angers, France , Annecy, France , Antony, France , Argenteuil, France , Aubenas, France , Bayonne, France and 66 more locations